BCR antibody (AA 139-280)

Catalog No. ABIN5611129

This anti-BCR antibody is a Mouse Monoclonal antibody detecting BCR in WB, ELISA and FACS. Suitable for Human.

Quick Overview for BCR antibody (AA 139-280) (ABIN5611129)

Target: BCR (Breakpoint Cluster Region (BCR))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This BCR antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Flow Cytometry (FACS)

Clone: 1E11G12

Product Details anti-BCR Antibody

Binding Specificity: AA 139-280

Purpose: BCR Antibody

Purification: Purified antibody

Immunogen: Purified recombinant fragment of human BCR (AA: 139-280) expressed in E. Coli.

Isotype: IgG1

Application Details

Application Notes:

ELISA: 1/10000

FCM: 1/200 - 1/400

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Purified antibody in PBS with 0.05 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Target Details for BCR

Target: BCR (Breakpoint Cluster Region (BCR))

Alternative Name: BCR

Background: A reciprocal translocation between chromosomes 22 and 9 produces the Philadelphia chromosome, which is often found in patients with chronic myelogenous leukemia. The chromosome 22 breakpoint for this translocation is located within the BCR gene. The translocation produces a fusion protein which is encoded by sequence from both BCR and ABL, the gene at the chromosome 9 breakpoint. Although the BCR-ABL fusion protein has been extensively studied, the function of the normal BCR gene product is not clear. The protein has serine/threonine kinase activity and is a GTPase-activating protein for p21rac. Two transcript variants encoding different isoforms have been found for this gene.

Molecular Weight: 142.8 kDa

Gene ID: 613

UniProt: P11274

Pathways: Regulation of Leukocyte Mediated Immunity, Platelet-derived growth Factor Receptor Signaling